Imteyaz Qamar
- Ophthalmology top 5%
-
- Computational Drug Discovery Methods 6
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 2
-
- Biochemical and Molecular Research 2
-
- Enzyme Structure and Function 3
-
- Synthesis and biological activity 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Acute Myeloid Leukemia Research 2
Imteyaz Qamar
23 papers receiving 366 citations
Peers
Comparison fields: 5 of 81
- Ophthalmology 64
- Computational Theory and Mathematics 71
- Infectious Diseases 60
- Molecular Biology 147
- Reproductive Medicine 16
Countries citing papers authored by Imteyaz Qamar
This map shows the geographic impact of Imteyaz Qamar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imteyaz Qamar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imteyaz Qamar more than expected).
Fields of papers citing papers by Imteyaz Qamar
This network shows the impact of papers produced by Imteyaz Qamar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imteyaz Qamar. The network helps show where Imteyaz Qamar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Imteyaz Qamar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 19 | |
| 4 | 2024 | 18 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 20 | |
| 12 | 2020 | 0 | |
| 13 | 2020 | 16 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 1 | |
| 16 | 2019 | 3 | |
| 17 | 2015 | 4 | |
| 18 | 2010 | 30 | |
| 19 | 2009 | 24 | |
| 20 | Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients. | 2007 | 72 |
About Imteyaz Qamar
Imteyaz Qamar is a scholar working on Computational Theory and Mathematics, Toxicology and Infectious Diseases, having authored 27 papers that have together received 373 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Enzyme Structure and Function (3 papers), Synthesis and biological activity (2 papers), Biochemical and Molecular Research (2 papers), COVID-19 Clinical Research Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Ophthalmology (64 citations), Computational Theory and Mathematics (71 citations) and Infectious Diseases (60 citations). Imteyaz Qamar has collaborated with scholars based in India, South Korea and Nigeria. Frequent co-authors include Anshuman Chandra, N. Singh, Eun‐Yeung Gong, Keesook Lee, Arun Kumar, Santosh K. Gupta, Abdullah Mahmood Ali, Vineeta Bajaj, Vikrant Nain and Hyun Joo Lee. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.